Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Systemic Autoimmune Diseases on Treatment Outcomes and Radiation Toxicities in Patients with Stage I Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy: A Matched Case-Control Analysis.
Chen Z, Nonaka H, Onishi H, Nakatani E, Oguri M, Saito M, Aoki S, Marino K, Komiyama T, Kuriyama K, Araya M, Tominaga L, Saito R, Maehata Y, Shinohara R. Chen Z, et al. Among authors: maehata y. Cancers (Basel). 2022 Nov 30;14(23):5915. doi: 10.3390/cancers14235915. Cancers (Basel). 2022. PMID: 36497397 Free PMC article.
Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study.
Chen Z, Nonaka H, Onishi H, Nakatani E, Sato Y, Funayama S, Watanabe H, Komiyama T, Kuriyama K, Marino K, Aoki S, Araya M, Tominaga L, Saito R, Maehata Y, Oguri M, Saito M. Chen Z, et al. Among authors: maehata y. J Radiat Res. 2021 May 12;62(3):457-464. doi: 10.1093/jrr/rrab021. J Radiat Res. 2021. PMID: 33866376 Free PMC article.
Dose Prescription Methods in Stereotactic Body Radiotherapy for Small Peripheral Lung Tumors: Approaches Based on the Gross Tumor Volume Are Superior to Prescribing a Dose That Covers 95% of the Planning Target Volume.
Komiyama T, Saito M, Kuriyama K, Marino K, Aoki S, Saito R, Muramatsu J, Maehata Y, Ze C, Akita T, Yamada T, Sano N, Yoshizawa K, Kazunari A, Hidekazu S, Ueda K, Vu N, Onishi H. Komiyama T, et al. Among authors: maehata y. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820974030. doi: 10.1177/1533033820974030. Technol Cancer Res Treat. 2020. PMID: 33272112 Free PMC article.
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Onishi H, Shioyama Y, Matsumoto Y, Shibamoto Y, Miyakawa A, Suzuki G, Nishimura Y, Sasaki R, Miyawaki D, Kuriyama K, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehata Y, Nonaka H, Tominaga L, Saito M, Sano N, Yamada S. Onishi H, et al. Among authors: maehata y. J Radiat Res. 2020 May 22;61(3):426-430. doi: 10.1093/jrr/rraa015. J Radiat Res. 2020. PMID: 32219316 Free PMC article.
Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy.
Saito M, Suzuki T, Sugama Y, Marino K, Sano N, Komiyama T, Aoki S, Maehata Y, Yoshizawa K, Ashizawa K, Suzuki H, Ueda K, Miyasaka Y, Araya M, Takahashi H, Onishi H. Saito M, et al. Among authors: maehata y. J Radiat Res. 2020 May 22;61(3):487-493. doi: 10.1093/jrr/rraa013. J Radiat Res. 2020. PMID: 32211861 Free PMC article.
Evaluation of the target dose coverage of stereotactic body radiotherapy for lung cancer using helical tomotherapy: A dynamic phantom study.
Saito M, Suzuki H, Sano N, Ashizawa K, Yoshizawa K, Shibata Y, Ueda K, Komiyama T, Marino K, Aoki S, Saito R, Maehata Y, Onishi H. Saito M, et al. Among authors: maehata y. Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):200-205. doi: 10.1016/j.rpor.2020.01.001. Epub 2020 Jan 14. Rep Pract Oncol Radiother. 2020. PMID: 32021577 Free PMC article.
Risk factors for reflux esophagitis after eradication of Helicobacter pylori.
Harada A, Kurahara K, Moriyama T, Tanaka T, Nagata Y, Kawasaki K, Yaita H, Maehata Y, Umeno J, Oshiro Y, Fuchigami T, Kitazono T, Esaki M, Matsumoto T. Harada A, et al. Among authors: maehata y. Scand J Gastroenterol. 2019 Oct;54(10):1183-1188. doi: 10.1080/00365521.2019.1671487. Epub 2019 Oct 2. Scand J Gastroenterol. 2019. PMID: 31577454
90 results